Desire and the ethics of advertising by Fuller, J

Backpropagation in time-series forecasting / by 431444 Lachtermacher, Gerson, Fuller, J. David

Can AI help in crowdsourcing? A theory-based model for idea screening in crowdsourcing contests by Bell, JJ, Pescher, C, Tellis, GJ, Füller, J

Can AI help in crowdsourcing? testing alternate algorithms for idea screening in crowdsourcing contests by Bell, J, Pescher, C, Tellis, GJ, Fuller, J

Mentoring for population health in general practice divisions. by Moss, JR, Mickan, S, Fuller, J, Procter, N, Waters, B, O'Rourke, P

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Thomason, M, Fuller, J

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke by Newman, C, Szarek, M, Hitman, G, Colhoun, H, Betteridge, D, Durrington, P, Neil, H, Livingstone, S, Fuller, J

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. by Thomason, M, Colhoun, H, Livingstone, S, Mackness, M, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Fuller, J

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. by Colhoun, H, Thomason, M, Mackness, M, Maton, S, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Fuller, J

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). by Hitman, G, Colhoun, H, Newman, C, Szarek, M, Betteridge, D, Durrington, P, Fuller, J, Livingstone, S, Neil, H

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS) by DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Fuller, J

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). by Neil, H, DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Livingstone, S, Fuller, J, Hitman, G

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS) by Newman, C, Szarek, M, Demicco, D, Hitman, G, Colhoun, H, Betteridge, D, Durrington, P, Neil, H, Livingston, S, Fuller, J

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS). by Newman, C, Szarek, M, Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Demicco, D, Auster, S, Fuller, J

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS) by Hitman, G, Newman, C, Szarek, M, Colhoun, H, Betteridge, J, Durrington, P, Neil, A, Livingstone, S, Fuller, J, Investigators, CARDS

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Charlton-Menys, V, DeMicco, D, Fuller, J

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. by Soedamah-Muthu, S, Colhoun, H, Thomason, M, Betteridge, D, Durrington, P, Hitman, G, Fuller, J, Julier, K, Mackness, M, Neil, H

A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms. by Ussher, M, Aveyard, P, Reid, F, West, R, Evans, P, Clow, A, Hucklebridge, F, Fuller, J, Ibison, J, Steptoe, A

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlle... by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Thomason, M, Mackness, M, Charlton-Menys, V, Fuller, J

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). by Raikou, M, McGuire, A, Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Charlton-Menys, V, Fuller, J